OPSIS THERAPEUTICS Trademark

Trademark Overview

On Tuesday, June 30, 2020, a trademark application was filed for OPSIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OPSIS THERAPEUTICS trademark a serial number of 90027853. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2024. This trademark is owned by Opsis Therapeutics, LLC. The OPSIS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Biological preparations derived from human stem cells for the treatment of ocular disorders; living tissue grafts for surgical implantation for the treatment of ocular disorders

Implants comprising natural, non-living materials derived from human stem cells useful for treatment of ocular disorders, namely, non-living tissue grafts for surgical implantation
opsis therapeutics

General Information

Serial Number90027853
Word MarkOPSIS THERAPEUTICS
Filing DateTuesday, June 30, 2020
Status700 - REGISTERED
Status DateTuesday, July 2, 2024
Registration Number7434279
Registration DateTuesday, July 2, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 30, 2021

Trademark Statements

Goods and ServicesBiological preparations derived from human stem cells for the treatment of ocular disorders; living tissue grafts for surgical implantation for the treatment of ocular disorders
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesImplants comprising natural, non-living materials derived from human stem cells useful for treatment of ocular disorders, namely, non-living tissue grafts for surgical implantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 28, 2020
Primary Code005
First Use Anywhere DateSaturday, May 4, 2024
First Use In Commerce DateSaturday, May 4, 2024
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 28, 2020
Primary Code010
First Use Anywhere DateSaturday, May 4, 2024
First Use In Commerce DateSaturday, May 4, 2024

Trademark Owner History

Party NameOpsis Therapeutics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMadison, WI 53711
Party NameOpsis Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMadison, WI 53711
Party NameOpsis Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMadison, WI 53711

Trademark Events

Event DateEvent Description
Friday, July 3, 2020NEW APPLICATION ENTERED
Tuesday, July 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 5, 2020ASSIGNED TO EXAMINER
Monday, October 5, 2020NON-FINAL ACTION WRITTEN
Monday, October 5, 2020NON-FINAL ACTION E-MAILED
Monday, October 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 30, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 27, 2021SOU TEAS EXTENSION RECEIVED
Monday, September 27, 2021SOU EXTENSION 1 FILED
Monday, March 28, 2022SOU EXTENSION 2 FILED
Monday, September 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, September 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 28, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 28, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 22, 2022SOU EXTENSION 3 FILED
Thursday, September 22, 2022SOU EXTENSION 3 GRANTED
Saturday, September 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023SOU EXTENSION 4 FILED
Tuesday, March 28, 2023SOU EXTENSION 4 GRANTED
Thursday, March 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU EXTENSION 5 FILED
Thursday, December 28, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, December 28, 2023PETITION TO REVIVE-GRANTED
Thursday, December 28, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, December 28, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, December 28, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, February 14, 2024SOU EXTENSION 5 GRANTED
Thursday, May 9, 2024USE AMENDMENT FILED
Tuesday, February 13, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 9, 2024TEAS STATEMENT OF USE RECEIVED
Friday, May 24, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 24, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics opsis ocular disorders treatment living human surgical implantation tissue grafts cells